Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Molecular Properties Property Value Systematic Name Aib-His-D-2-Nal-D-Phe-Lys-NH Molecular Formula CHNO Molecular Weight 711.85 Da CAS Number 170851-70-4 Structure Class Synthetic pentapeptide Receptor Target GHS-R1a (growth hormone secretagogue receptor type 1a) Development Novo Nordisk (NNC 26-0161) The sequence includes -aminoisobutyric acid (Aib) at position 1, D-2-naphthylalanine (D-2-Nal) at position 3, and D-phenylalanine (D-Phe) at position 4
Tirzepatide, which mimics GLP-1 plus the gut hormone GIP, was approved to treat type 2 diabetes (under the name Mounjaro) in May 2022
HIV infection is associated with acquired immune deficiency syndrome (AIDS) development
May Support PCOS GLP-1 medications are also being studied for their role in polycystic ovary syndrome (PCOS), particularly in patients with insulin resistance
These interacting pathways impair synaptic plasticity and stress resilience, helping explain the persistent emotional vulnerability seen in chronic ATS users
Clomiphene citrate (CC) plus L-Carnitine improves clinical pregnancy rate along with glycemic status and lipid profile in clomiphene-resistant polycystic ovary syndrome patients: a triple-blind randomized controlled clinical trial
US$ 29.86
US$ 20.35
US$ 24.02
